Kumaravel Rajakumar1, Charity G Moore2, Arshad T Khalid1, Abbe N Vallejo1, Mohamed A Virji3, Michael F Holick4, Susan L Greenspan5, Silva Arslanian1, Steven E Reis5. 1. Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. 2. Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, USA. 3. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 4. Department of Medicine, Boston University Medical Center, Boston, MA, USA. 5. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract
BACKGROUND:Obese children are vulnerable to vitamin D deficiency and impaired cardiovascular health; vitamin D replenishment might improve their cardiovascular health. OBJECTIVES: The aims were to determine, in vitamin D-deficient overweight and obese children, whether supplementation with vitamin D3 1000 or 2000 IU/d is more effective than 600 IU/d in improving arterial endothelial function, arterial stiffness, central and systemic blood pressure (BP), insulin sensitivity (1/fasting insulin concentration), fasting glucose concentration, and lipid profile and to explore whether downregulation of adipocytokines and markers of systemic inflammation underlies vitamin D effects. METHODS: We conducted a randomized, double-masked, controlled clinical trial in 225 10- to 18-y-old eligible children. Change in endothelial function at 6 mo was the primary outcome. RESULTS: Dose-response increases in serum 25-hydroxyvitamin D concentrations were significant and tolerated without developing hypercalcemia. Changes at 3 and 6 mo in endothelial function, arterial stiffness, systemic-systolic BP, lipids, and inflammatory markers did not differ between children receiving 1000 or 2000 IU vitamin D and children receiving 600 IU. Some secondary outcomes differed between groups. Compared with the 600-IU group, central-systolic, central-diastolic, and systemic-diastolic BP was lower at 6 mo in the 1000-IU group [-2.66 (95% CI: -5.27, -0.046), -3.57 (-5.97, -1.17), and -3.28 (-5.55, -1.00) mm Hg, respectively]; insulin sensitivity increased at 3 and 6 mo and fasting glucose concentration declined at 6 mo (-2.67; 95% CI: -4.88, -0.46 mg/dL) in the 2000-IU group. CONCLUSIONS: Correction of vitamin D deficiency in overweight and obese children by vitamin D3 supplementation with 1000 or 2000 IU/d versus 600 IU/d did not affect measures of arterial endothelial function or stiffness, systemic inflammation, or lipid profile, but resulted in reductions in BP and fasting glucose concentration and in improvements in insulin sensitivity. Optimization of children's vitamin D status may improve their cardiovascular health. This trial was registered at clinicaltrials.gov as NCT01797302.
RCT Entities:
BACKGROUND:Obesechildren are vulnerable to vitamin Ddeficiency and impaired cardiovascular health; vitamin D replenishment might improve their cardiovascular health. OBJECTIVES: The aims were to determine, in vitamin D-deficient overweight and obesechildren, whether supplementation with vitamin D3 1000 or 2000 IU/d is more effective than 600 IU/d in improving arterial endothelial function, arterial stiffness, central and systemic blood pressure (BP), insulin sensitivity (1/fasting insulin concentration), fasting glucose concentration, and lipid profile and to explore whether downregulation of adipocytokines and markers of systemic inflammation underlies vitamin D effects. METHODS: We conducted a randomized, double-masked, controlled clinical trial in 225 10- to 18-y-old eligible children. Change in endothelial function at 6 mo was the primary outcome. RESULTS: Dose-response increases in serum 25-hydroxyvitamin D concentrations were significant and tolerated without developing hypercalcemia. Changes at 3 and 6 mo in endothelial function, arterial stiffness, systemic-systolic BP, lipids, and inflammatory markers did not differ between children receiving 1000 or 2000 IU vitamin D and children receiving 600 IU. Some secondary outcomes differed between groups. Compared with the 600-IU group, central-systolic, central-diastolic, and systemic-diastolic BP was lower at 6 mo in the 1000-IU group [-2.66 (95% CI: -5.27, -0.046), -3.57 (-5.97, -1.17), and -3.28 (-5.55, -1.00) mm Hg, respectively]; insulin sensitivity increased at 3 and 6 mo and fasting glucose concentration declined at 6 mo (-2.67; 95% CI: -4.88, -0.46 mg/dL) in the 2000-IU group. CONCLUSIONS: Correction of vitamin Ddeficiency in overweight and obesechildren by vitamin D3 supplementation with 1000 or 2000 IU/d versus 600 IU/d did not affect measures of arterial endothelial function or stiffness, systemic inflammation, or lipid profile, but resulted in reductions in BP and fasting glucose concentration and in improvements in insulin sensitivity. Optimization of children's vitamin D status may improve their cardiovascular health. This trial was registered at clinicaltrials.gov as NCT01797302.
Authors: Sanne A E Peters; Michiel L Bots; Hester M den Ruijter; Mike K Palmer; Diederick E Grobbee; John R Crouse; Daniel H O'Leary; Gregory W Evans; Joel S Raichlen; Karel G M Moons; Hendrik Koffijberg Journal: J Clin Epidemiol Date: 2012-03-27 Impact factor: 6.437
Authors: Joon Young Kim; Sara F Michaliszyn; Alexis Nasr; SoJung Lee; Hala Tfayli; Tamara Hannon; Kara S Hughan; Fida Bacha; Silva Arslanian Journal: Diabetes Care Date: 2016-06-12 Impact factor: 19.112
Authors: Ashley J Ferira; Emma M Laing; Dorothy B Hausman; Daniel B Hall; George P McCabe; Berdine R Martin; Kathleen M Hill Gallant; Stuart J Warden; Connie M Weaver; Munro Peacock; Richard D Lewis Journal: J Clin Endocrinol Metab Date: 2016-02-17 Impact factor: 5.958
Authors: John D Sluyter; Carlos A Camargo; Alistair W Stewart; Debbie Waayer; Carlene M M Lawes; Les Toop; Kay-Tee Khaw; Simon A McG Thom; Bernhard Hametner; Siegfried Wassertheurer; Kim H Parker; Alun D Hughes; Robert Scragg Journal: J Am Heart Assoc Date: 2017-10-24 Impact factor: 5.501
Authors: Stefan Sebastian Busnatu; Liviu Ionut Serbanoiu; Andreea Elena Lacraru; Catalina Liliana Andrei; Cosmina Elena Jercalau; Marilena Stoian; Anca Stoian Journal: Healthcare (Basel) Date: 2022-01-01
Authors: John P Bilezikian; Anna Maria Formenti; Robert A Adler; Neil Binkley; Roger Bouillon; Marise Lazaretti-Castro; Claudio Marcocci; Nicola Napoli; Rene Rizzoli; Andrea Giustina Journal: Rev Endocr Metab Disord Date: 2021-12-23 Impact factor: 6.514
Authors: Norma C Serrano; Sandra L Romero; Diana P Suárez; Lyda Z Rojas; Edna Magaly Gamboa-Delgado; Mario Forero; Elizabeth Guio; Doris Cristina Quintero-Lesmes Journal: Medicine (Baltimore) Date: 2020-08-28 Impact factor: 1.817